Issue Information – Table of Contents
Red cell survival and NO scavenging in sickle cell disease
Impact of emergency department care on outcomes of acute pain events in children with sickle cell disease
A diagnostic nomogram for delayed hemolytic transfusion reaction in sickle cell disease
Rapidly progressive acute chest syndrome in individuals with sickle cell anemia
Transcranial doppler re‐screening of subjects who participated in STOP and STOP II
Biochemical surrogate markers of hemolysis do not correlate with directly measured erythrocyte survival in sickle cell anemia
Rare HFE variants are the most frequent cause of hemochromatosis in non‐c282y homozygous patients with hemochromatosis
Long‐term bosutinib for chronic phase chronic myeloid leukemia after failure of imatinib plus dasatinib and/or nilotinib
Investigation of chromosome X inactivation and clinical phenotypes in female carriers of DKC1 mutations
Peripheral blood blast clearance is an independent prognostic factor for survival and response to acute myeloid leukemia induction chemotherapy
Clonal hematopoiesis in patients with dyskeratosis congenita
Mutations in idiopathic cytopenia of undetermined significance assist diagnostics and correlate to dysplastic changes
Karyotype plus NPM1 mutation status defines a group of elderly patients with AML (≥60 years) who benefit from intensive post‐induction consolidation therapy
Efficacy of a rituximab regimen based on B cell depletion in thrombotic thrombocytopenic purpura with suboptimal response to standard treatment
2017 Clinical trials update
Primary myelofibrosis
Neuroblastoma in the bone marrow
Fanconi anemia in 55‐year‐old identical twins first presenting as fatal post‐chemotherapy pancytopenia
Molecular testing for JAK2, MPL, and CALR in myeloproliferative neoplasms
A giant adrenal myelolipoma in a beta‐thalassemia major patient
Reversible kidney iron accumulation in a patient with sickle cell disease treated with hydroxyurea
Iron refractory iron deficiency anemia
A retrospective comparative outcome analysis following systemic therapy in Mycosis fungoides and Sezary syndrome
Reports to FDA of fatal anaphylaxis associated with intravenous iron products
Reply to McCulley et al., reports to FDA of fatal anaphylaxis associated with intravenous iron products
Safety and effectiveness of extended versus shortened iron dextran infusion time for the treatment of iron deficiency anemia
Risk factors associated with intracranial hemorrhage in adults with immune thrombocytopenia
Erythrocyte adenosine deaminase levels are elevated in Diamond Blackfan anemia but not in the 5q− syndrome
Myeloma minimal residual disease testing in the United States
Presence of B‐cell precursors in bone marrow is a favorable independent prognostic factor for overall survival in patients with myelodysplastic syndromes
Phase II trial of nab‐paclitaxel in patients with relapsed or refractory multiple myeloma
Encapsulated relapsed FLT3+AML (myeloid sarcoma) and Hürthle cell adenoma presenting in composite
Organ response in patients with AL amyloidosis treated with NEOD001, an amyloid‐directed monoclonal antibody